Inhibition of mouse testicular DNA synthesis by mutagens and carcinogens as a potential sample mammalian assay for mutagenesis.
Since mutagenic substances induce structural changes in DNA, studies were undertaken to determine whether substances would modify DNA replicative activity. DNA synthesis was quantitated 3.5 h after drug administration as uptake into DNA of a 30-min pulse of 10 muCi of [3H] thymidine. Combinations of methylurea (20000 mg/kg) and sodium nitrite (150 mg/kg) administered p.o. resulted in gastric synthesis of nitrosomethylurea and inhibited testicular DNA synthesis by 83%. Combinations of methylurea and sodium nitrite of 1000 and 100 mg/kg respectively inhibited DNA synthesis by 75%. With dimethylamine and sodium nitrite, a combination which results in gastric synthesis of dimethylnitrosamine, inhibitions of 65 and 57% were observed at 2000 mg/kg together with 150 mg/kg and 1000 mg/kg in combination with 100 mg/kg, respectively. In separate experiments, dimethylnitrosamine (50 mg/kg, p.o.) and diethylnitrosamine (100 mg/kg, i.p.) inhibited thymidine uptake by 30 and 89%, respectively. The mutagenic polynucelar hydrocarbon 3-methylcholanthrene (15 mg/kg) inhibited DNA synthesis by 95% and safrole (640 mg/kg), a mutagenic methylenedioxybenzene derivative, inhibited by 60%. Cadmium chloride (10 mg/kg), acetylaminofluorene (160 mg/kg) and dibutylnitrosamine (500 mg/kg) also induced statistically significant effects. Noncarcinogenic analogues of these substances (anthracene, 125 mg/kg; diphenyl-nitrosamine, 500 mg/kg; piperonyl butoxide, 640 mg/kg, and methylurea, 2000 mg/kg in combination with sodium nitrate) were inactive. Highly toxic substances (potassium cyanide, 2.5 mg/kg; 2,4-dinitrophenol, 20 mg/kg; and lead acetate, 150 mg/kg) were also inactive. This index of mutagenicity appears to have considerable sensitivity and therefore may have potential in drug evaluation.
D000818:Animals; D002104:Cadmium / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology*; D004261:DNA Replication / Q000187:drug effects*; D004048:Diethylamines / Q000494:pharmacology; D008297:Male; D008782:Methylurea Compounds / Q000494:pharmacology; D051379:Mice; D009153:Mutagens / Q000494:pharmacology*; D009573:Nitrites / Q000494:pharmacology; D009602:Nitrosamines / Q000378:metabolism; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D012451:Safrole / Q000494:pharmacology; D013737:Testis / Q000187:drug effects* / Q000378:metabolism
D002273:Carcinogens; D004048:Diethylamines; D008782:Methylurea Compounds; D009153:Mutagens; D009573:Nitrites; D009602:Nitrosamines; D009607:Nitrosourea Compounds; D002104:Cadmium; D012451:Safrole